Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenue
461
393
324
252
203
187
Revenue Growth (YoY)
22%
21%
28.99%
24%
9%
21%
Cost of Revenue
392
339
264
200
162
150
Gross Profit
68
53
59
52
40
36
Selling, General & Admin
102
107
113
119
83
41
Research & Development
--
--
--
--
--
--
Operating Expenses
109
114
119
124
86
45
Other Non Operating Income (Expenses)
-14
2
0
85
29
-6
Pretax Income
-66
-64
-83
0
-11
-14
Income Tax Expense
0
0
0
0
0
0
Net Income
-54
-53
-67
0
-10
-14
Net Income Growth
-5%
-21%
--
-100%
-28.99%
250%
Shares Outstanding (Diluted)
97.47
75.04
73.74
80.6
73.2
74.6
Shares Change (YoY)
28.99%
2%
-9%
10%
-2%
0%
EPS (Diluted)
-0.56
-0.7
-0.92
0
-0.15
-0.19
EPS Growth
-27%
-23%
--
-100%
-21%
280%
Free Cash Flow
-27
-30
-40
-67
-35
0
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
14.75%
13.48%
18.2%
20.63%
19.7%
19.25%
Operating Margin
-8.89%
-15.26%
-18.51%
-28.57%
-22.16%
-4.27%
Profit Margin
-11.71%
-13.48%
-20.67%
0%
-4.92%
-7.48%
Free Cash Flow Margin
-5.85%
-7.63%
-12.34%
-26.58%
-17.24%
0%
EBITDA
-34
-54
-55
-68
-42
-5
EBITDA Margin
-7.37%
-13.74%
-16.97%
-26.98%
-20.68%
-2.67%
D&A For EBITDA
7
6
5
4
3
3
EBIT
-41
-60
-60
-72
-45
-8
EBIT Margin
-8.89%
-15.26%
-18.51%
-28.57%
-22.16%
-4.27%
Effective Tax Rate
0%
0%
0%
0%
0%
0%
Follow-Up Questions
What are Altair Corp's key financial statements?
According to the latest financial statement (Form-10K), Oncology Institute Inc has a total asset of $172, Net loss of $-53
What are the key financial ratios for ATCD?
Oncology Institute Inc's Current ratio is 1.01, has a Net margin is -13.48, sales per share of $5.23.
How is Altair Corp's revenue broken down by segment or geography?
Oncology Institute Inc largest revenue segment is Patient Services, at a revenue of 213,504,000 in the most earnings release.For geography, United States is the primary market for Oncology Institute Inc, at a revenue of 324,239,000.
Is Altair Corp profitable?
no, according to the latest financial statements, Oncology Institute Inc has a net loss of $-53
Does Altair Corp have any liabilities?
yes, Oncology Institute Inc has liability of 169
How many outstanding shares for Altair Corp?
Oncology Institute Inc has a total outstanding shares of 75.73